About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 139 record(s)
Req # A-2021-000737
Adverse Drug Reactions (ADRs). Report numbers: E2B_02387664, E2B_02436469, E2B_03196067, E2B_02509216, E2B_02514076, E2B_02530758, E2B_02540489, E2B_02504374, E2B_02517337, E2B_02532195, E2B_02550886, E2B_02084810, E2B_01257851, E2B_02136666,…Organization: Health Canada
November 2021
Req # A-2021-000774
Adverse Drug Reactions (ADRs). Report numbers: E2B_03201447, E2B_03101486, E2B_03328634, E2B_03345194, E2B_03368590, E2B_03362118, E2B_03345202, E2B_03362390, E2B_03362381, E2B_03365231, E2B_03362409, E2B_03074898, 000729626, E2B_02890074, 000925315…Organization: Health Canada
November 2021
Req # A-2021-000778
Adverse Drug Reaction (ADR) for Zostavax. Report number: 000706855. ADRs for Emend. Report number: E2B_01657462, E2B_01887485, E2B_01892612, E2B_02106832, 000721787, E2B_01657462, E2B_02240055, E2B_01690855, E2B_01693832.Organization: Health Canada
November 2021
Req # A-2021-000809
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03491999, E2B_03356729, E2B_03498916, E2B_03494439, E2B_03343928, E2B_03346951, E2B_03443238, E2B_03320703, 000930614, E2B_03323215, E2B_03463305, E2B_03451461,…Organization: Health Canada
November 2021
Req # A-2021-000816
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03478100, 000922477, E2B_03371078, E2B_03374635, E2B_03374656, E2B_03295674, E2B_03371446, E2B_03378196, E2B_03475074, E2B_03318209, E2B_03374641, E2B_03328936, E2B_03298379,…Organization: Health Canada
November 2021
Req # A-2021-000817
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03278661, E2B_03323154, 000924141, E2B_03375514, E2B_03289451, E2B_03292157, E2B_03324085, 000925433, E2B_03328913, E2B_03457334, E2B_03383035, E2B_03477245, E2B_03372855,…Organization: Health Canada
November 2021
Req # A-2021-000823
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: 000922977, E2B_03482740, E2B_03502689, E2B_03519453, 000920609, 000919173, E2B_03443555, E2B_03334250, E2B_03501842, E2B_03501706, E2B_03449685, E2B_03413136, 000922507,…Organization: Health Canada
November 2021
Req # A-2021-000830
Adverse Drug Reactions (ADRs) for DOCETAXEL. Report numbers: E2B_03501632, 000925480, E2B_03401254, E2B_03397787, E2B_03370868, E2B_03321556, 000922461, 000920224, E2B_03345202, 000925443, E2B_03403664, E2B_03370877, 000920350, 000920879,…Organization: Health Canada
November 2021
Req # A-2021-000837
Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: 000925817, 000925838, E2B_03495844, E2B_03427725, E2B_03391240, E2B_03502948, E2B_03496124, E2B_03379530, E2B_03497089, 000923501, E2B_03503405, 000923948, E2B_03490319, 000921817,…Organization: Health Canada
November 2021
Req # A-2021-000840
Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: E2B_03487570, 000925826, E2B_03502085.Organization: Health Canada
November 2021